Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.450
-0.070 (-4.61%)
Jun 10, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Employees
Context Therapeutics had 15 employees as of December 31, 2025. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$2,681,795
Market Cap
133.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 3 | 25.00% |
| Dec 31, 2024 | 12 | 7 | 140.00% |
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | - | - |
| Jun 30, 2021 | 2 | - | - |
| Mar 31, 2021 | 2 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Molecular Partners AG | 134 |
| Alpha Cognition | 71 |
| Connect Biopharma Holdings | 64 |
| Corbus Pharmaceuticals Holdings | 36 |
| Jyong Biotech | 27 |
| Genelux | 26 |
| Spero Therapeutics | 25 |
CNTX News
- 23 hours ago - Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 days ago - Context Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 14 days ago - Context Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 23 days ago - Context Therapeutics enters license agreement amendment with BioAtla - TheFly
- 23 days ago - Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 - GlobeNewsWire
- 4 weeks ago - Context Therapeutics reports Q1 EPS (9c), consensus (12c) - TheFly
- 4 weeks ago - Context Therapeutics Reports First Quarter 2026 Operating and Financial Results - GlobeNewsWire
- 5 weeks ago - Context Therapeutics Quarterly report: Q1 2026 - Filings